| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0300-483X(02)00252-4 |
| P698 | PubMed publication ID | 12505282 |
| P50 | author | Raffaella Romeo | Q47504215 |
| P2093 | author name string | Massimo Colombo | |
| P2860 | cites work | Prognosis of hepatocellular carcinoma: the BCLC staging classification | Q29619984 |
| Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials | Q34068152 | ||
| Hepatocellular carcinoma: Recent progress | Q35227361 | ||
| Hepatocellular carcinoma and sex hormones | Q35236924 | ||
| Hepatocellular carcinoma: possible etiologies in patients without serologic evidence of hepatitis B virus infection | Q38266012 | ||
| Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers | Q43640037 | ||
| Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma | Q45844527 | ||
| p53 mutation in hepatocellular carcinoma after aflatoxin exposure | Q46975262 | ||
| Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study. | Q53443840 | ||
| Hepatocellular carcinoma | Q67494896 | ||
| Hepatocellular carcinoma in Italian patients with cirrhosis | Q68249092 | ||
| No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group | Q71997601 | ||
| Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study | Q72590102 | ||
| Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization | Q73107820 | ||
| Small hepatic nodules in cirrhosis: ultrasonographic, CT, and MR imaging findings | Q77954169 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 39-42 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Toxicology | Q1666328 |
| P1476 | title | The natural history of hepatocellular carcinoma | |
| P478 | volume | 181-182 |
| Q34035372 | Contribution of gut bacteria to liver pathobiology |
| Q43048304 | Effect of Qi-protecting powder (Huqi San) on expression of c-jun, c-fos and c-myc in diethylnitrosamine-mediated hepatocarcinogenesis |
| Q27490242 | Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma |
| Q35882733 | Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis |
| Q48003450 | Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer |
| Q35615755 | Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients. |
| Q42875933 | Mechanical stiffness of liver tissues in relation to integrin β1 expression may influence the development of hepatic cirrhosis and hepatocellular carcinoma |
| Q36618666 | Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis |
| Q35206102 | TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients |
| Q35081944 | The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer. |
| Q37038364 | Transcatheter arterial chemoembolization and percutaneous ethanol injection for Hepatocellular carcinoma: a retrospective review of the Veterans Affairs Caribbean Healthcare System |
Search more.